InMode Ltd. (INMD) 株式分析

企業概要

InMode Ltd. is a leading provider of minimally invasive aesthetic medical products, utilizing proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies to deliver treatments across the United States, Europe, Asia, and internationally. This business operates within the broader Healthcare sector, specifically focusing on the Medical Devices industry, where innovation in non-invasive and minimally invasive procedures is central to its market positioning. The company demonstrates a significant operational scale, with a current market capitalization of 8.6738 億ドル (867.38M 米ドル) and an annual revenue of 3.7050 億ドル (370.50M 米ドル) over the trailing twelve months. Employing a workforce of 660 名 (employees), InMode's substantial market cap and robust revenue base indicate a well-established position in the global aesthetic medicine landscape, suggesting a firm that has successfully scaled its proprietary technology to generate consistent commercial traction.

財務健全性

InMode Ltd. reported a revenue of 3.7050 億ドル (370.50M 米ドル) for the trailing twelve months, generating a net income of 93.83 百万ドル (93.83M 米ドル) and an EBITDA of 86.08 百万ドル (86.08M 米ドル). The gap between the total revenue and the net income reveals a highly efficient cost structure, as the company manages its expenses effectively to convert a large portion of sales into actual profit. The company maintains strong financial flexibility with free cash flow of 39.10 百万ドル (39.10M 米ドル), indicating a robust ability to fund operations, invest in research, or manage capital returns without relying on external financing. Margin analysis highlights exceptional profitability, with a gross margin of 78.5%, an operating margin of 25.0%, and a profit margin of 25.3%, all of which reflect the high-value nature of its proprietary medical device portfolio and effective operational control. The balance sheet is exceptionally conservative, evidenced by cash holdings of 5.5533 億ドル (555.33M 米ドル) vastly exceeding total debt of 8.23 百万ドル (8.23M 米ドル), while the debt-to-equity ratio of 1.20 further underscores a low-leverage financial structure. Short-term liquidity is extremely robust, as indicated by a current ratio of 9.88, which suggests the company holds nearly ten times the current assets required to settle its short-term liabilities. Furthermore, the Return on Equity stands at 13.5% and the Return on Assets is 6.9%, metrics that collectively reveal management's effectiveness in utilizing shareholder capital and assets to generate substantial economic returns.

バリュエーション評価

In terms of valuation multiples, InMode Ltd. trades at a trailing P/E ratio of 9.57 and a forward P/E of 8.94. The difference between these two ratios, where the forward P/E is lower than the trailing P/E, implies that the market expects earnings to grow or at least stabilize in the near future relative to current levels. The price-to-book ratio is 1.27, which indicates that the market values the company slightly above its net asset book value, reflecting confidence in its intangible assets and brand equity beyond the tangible balance sheet items. Alternative valuation metrics such as the price-to-sales ratio of 2.34 and an EV/EBITDA of 3.72 suggest that the company is valued reasonably relative to its sales volume and enterprise earnings, supporting its status as a profitable growth-stage firm. Regarding price metrics, the 52-week high is recorded at 16.74 米ドル and the 52-week low at 12.72 米ドル; without the specific current share price provided in the facts, the precise percentage deviation from this range cannot be calculated, though the trading range highlights the recent volatility within the asset's price history. The stock exhibits a beta of 2.12, which signifies that the share price is significantly more volatile than the broader market, moving with a higher degree of sensitivity to market-wide fluctuations and investor sentiment shifts.

Growth & Income

The company's growth profile shows a revenue growth rate of 6.1% year-over-year, while earnings growth for the same period is -63.5%. This divergence indicates that earnings are currently declining at a much faster rate than revenue, which implies a temporary disconnect between top-line expansion and bottom-line performance, potentially due to non-recurring costs or adjustments in the earnings structure. As a non-dividend payer, InMode Ltd. has a dividend yield of N/A and a payout ratio of 0.0%, meaning the company reinvests all of its earnings into growth initiatives, R&D, and operational expansion rather than distributing cash to shareholders. This reinvestment strategy is typical for companies in the medical device sector that prioritize long-term market share acquisition and technological advancement over immediate income distribution to investors. Overall, the growth and income profile presents a picture of a mature yet expanding business that sacrifices current income distribution to fuel future revenue expansion and maintain its competitive edge in the aesthetic medical device market.